Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study: an Open-label Randomized Controlled Trial

NCT04746430 is registered in ClinicalTrials.gov with General Practitioners Research Institute as lead sponsor.

NCT NCT04746430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04746430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study: an Open-label Randomized Controlled Trial
Lead sponsor
General Practitioners Research Institute
Phase
Phase 4
Overall status
Terminated
Start date
February 16, 2021
Completion date
April 23, 2021
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid19